0.75 USD
↘ 0.00 (0.15%)AT CLOSE (11:59 AM EDT)
Estrella Immunopharma, Inc. Common Stock
ESLANASDAQ • USD
0.74
↘ 0.00 (0.26%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
0.74
↘ 0.00 (0.26%)
Market: CLOSED
ESLA is currently priced at $0.77. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (251.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Aug 6, 2026.
Open?$0.77
High?$0.78
Low?$0.71
Prev. Close?$0.75
Volume?13.9K
Avg. Volume?45.3K
VWAP?$0.76
Rel. Volume?0.31x
Bid / Ask
Bid?$0.70 × 1.6K
Ask?$0.99 × 100
Spread?$0.29
Midpoint?$0.84
Valuation & Ratios
Market Cap?32.3M
Shares Out?43.0M
Float?15.1M
Float %?35.2%
P/E Ratio?N/A
P/B Ratio?-6.12
EPS?-$0.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Employees
N/A
Market Cap
32.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098
EMERYVILLE, CA 94608
Phone: (510) 318-9098
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-27.05Distress
Confidence?36%Very Low
Short InterestLow
Short % of Float?0.36%Low
Short Interest?54.5K
Days to Cover?1.2
Free Float15.1M
Avg Daily Volume45.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?0.24Weak
Quick Ratio?0.24Weak
Cash Ratio?0.22Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-6.12CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?251.4%STRONG▾
Peers50
S&P97
ROA?-362.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$30.3M
Fundamentals ratios updated end of day